Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.29
+0.06 (0.83%)
At close: Feb 27, 2026, 4:00 PM EST
7.28
-0.01 (-0.14%)
After-hours: Feb 27, 2026, 7:14 PM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.9 billion as of February 27, 2026. Its market cap has decreased by -50.71% in one year.
Market Cap
1.90B
Enterprise Value
10.12B
1-Year Change
-50.71%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.90B, a decrease of -77.45%. That is a compound annual growth rate of -26.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 1.88B | 0.97% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 155.48B |
| Bristol-Myers Squibb Company | 125.69B |
| GSK plc | 117.42B |
| Sanofi | 115.20B |
| Biogen | 27.93B |
| Grifols | 7.90B |
| Amarin Corporation | 286.94M |
| Nasus Pharma | 54.43M |